Simplify Logo

Full-Time

Vice President

Clinical Development, Early Oncology Development

Posted on 5/6/2024

Scorpion Therapeutics

Scorpion Therapeutics

51-200 employees

Develops targeted small-molecule cancer drugs

Data & Analytics
Hardware
Biotechnology

Senior

San Francisco, CA, USA

Category
Healthcare Administration & Support
Physicians & Surgeons
Medical, Clinical & Veterinary
Required Skills
Communications
Requirements
  • MD, PhD, or equivalent
  • Minimum of 5 years of experience in oncology clinical development
  • Experience in conducting early phase oncology trials (Phase I/II)
  • Experience in small molecule targeted therapeutics in oncology
  • Experience with medical monitoring
  • Knowledge and experience in clinical trial design, safety, pharmacokinetics, and pharmacodynamics
  • Experience in clinical trial and data management
  • Knowledge of clinical trial regulations and Good Clinical Practices
  • Strong understanding of integrating pre-clinical and clinical data
  • Excellent written and verbal communication skills
  • Strong problem-solving and analytical skills
  • Ability to work efficiently in a multi-functional clinical program team
Responsibilities
  • Manage and provide medical oversight and monitoring of clinical programs
  • Develop, review, and assess clinical trial protocols and reports
  • Provide medical input on safety and efficacy decisions
  • Develop medical strategy for clinical development
  • Serve as key clinical representative for external-facing interactions
  • Establish relationships with key opinion leaders
  • Review and assess data from clinical trials
  • Collaborate with other line functions to assess trial data
  • Lead review of medical issues related to clinical trials
  • Work with clinical operations personnel to ensure study objectives are met
  • Participate in review of investigator and clinical site selection
  • Collaborate with external clinical experts and contract-research-organizations
  • Participate in strategic interactions with research discovery group
Scorpion Therapeutics

Scorpion Therapeutics

View

At Scorpion Therapeutics, our pursuit of advancing Precision Oncology 2.0, by developing targeted small-molecule drugs, makes us a leading edge in the field. With a focus on pioneering advancements in target discovery and medicinal chemistry, we are committed to overcoming the limitations of current cancer therapies. This creates a dynamic working environment, where employees are engaged in meaningful work that has the potential to significantly enhance patient outcomes in oncology.

Company Stage

Series A

Total Funding

$132.7M

Headquarters

Boston, Massachusetts

Founded

2020

Growth & Insights
Headcount

6 month growth

6%

1 year growth

11%

2 year growth

50%
INACTIVE